Physician

Adam Christopher Godsey

According to 2025 Medicare claims, Adam Godsey (NPI: 1932465523) practices gastroenterology in the Wausau, WI market, with the plurality of this provider's patient population coming from Marathon, WI. This provider's primary affiliated billing organization is GASTROINTESTINAL ASSOCIATES S.C. (NPI: 1760546949; TIN: 391735324) and primary practice location at 54401-4152. Godsey is affiliated with the THEDACARE ACO (ACO ID: A4988), participating under the MSSP model.

Godsey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 301 traditional Medicare patients, billed 6,312 HCPCS/CPT codes, and received $145,488 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,068 prescription claims across 272 beneficiaries totaling $336,499 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 1 records totaling $80. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $29,896 to $336,499. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$116K$232K2018 Medicare payment: $67,256 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $190,411 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $232,485 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $202,468 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $210,418 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $173,729 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $145,488 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018864,769$67,256
20192978,004$190,411
202031411,956$232,485
202135112,870$202,468
202230112,356$210,418
20233167,383$173,729
20243016,312$145,488

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$168K$336K2015 Drug cost: $29,896 (USD; Tot_Drug_Cst)2016 Drug cost: $4,839 (USD; Tot_Drug_Cst)2018 Drug cost: $49,923 (USD; Tot_Drug_Cst)2019 Drug cost: $186,029 (USD; Tot_Drug_Cst)2020 Drug cost: $117,978 (USD; Tot_Drug_Cst)2021 Drug cost: $230,218 (USD; Tot_Drug_Cst)2022 Drug cost: $197,344 (USD; Tot_Drug_Cst)2023 Drug cost: $282,433 (USD; Tot_Drug_Cst)2024 Drug cost: $336,499 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201553361$29,896
20161121$4,839
2017N/RN/RN/R
20182863$49,923
2019116428$186,029
2020150659$117,978
2021211851$230,218
2022215856$197,344
2023215847$282,433
20242721,068$336,499

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare9090$186
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6060$107
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5153$83
45380Biopsy of large bowel using a flexible endoscope2121$71
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope7678$63

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab13364$94,080
CreonLipase/Protease/Amylase23895$53,763
XifaxanRifaximin15402$51,255
LinzessLinaclotide522,010$36,103
MotegrityPrucalopride Succinate24720$12,551

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$80ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Christopher Godsey?

Tedicare shows public-source Medicare data for Adam Christopher Godsey (NPI 1932465523), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Christopher Godsey have ACO affiliation data?

Adam Christopher Godsey is shown with ACO affiliation data for THEDACARE ACO (MSSP, ACO ID A4988).

What billing organization is linked to Adam Christopher Godsey?

Adam Christopher Godsey is linked to GASTROINTESTINAL ASSOCIATES S.C. (billing NPI 1760546949) in the available physician profile data.

Does Adam Christopher Godsey have Open Payments data?

Adam Christopher Godsey has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.